<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02967445</url>
  </required_header>
  <id_info>
    <org_study_id>2156/15</org_study_id>
    <nct_id>NCT02967445</nct_id>
  </id_info>
  <brief_title>Physical Examination-Indicated Pessary</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Federico II University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Federico II University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cervical insufficiency, previously referred to as cervical incompetence, has classically been&#xD;
      defined as painless dilation of the cervix in the absence of contractions or bleeding in the&#xD;
      second trimester resulting in recurrent pregnancy losses. Painless mid-trimester cervical&#xD;
      dilation is an uncommon finding in the general population occurring in less than 1% of&#xD;
      pregnancies. Cerclage for the prevention pregnancy loss in cases with both prior preterm&#xD;
      births and/or second trimester losses, as well as second trimester cervical dilatation in the&#xD;
      index pregnancy, was first reported in the 1950's. Cerclage placement in this setting has&#xD;
      been variably referred to as &quot;physical exam-indicated cerclage&quot;, &quot;rescue cerclage&quot;, and&#xD;
      &quot;emergency cerclage&quot;. To date, the benefits of cerclage for this indication are not entirely&#xD;
      clear.&#xD;
&#xD;
      A recent meta-analysis showed that physical exam-indicated cerclage is associated with a&#xD;
      reduction in perinatal mortality and prolongation of pregnancy when compared to no such&#xD;
      cerclage.&#xD;
&#xD;
      Recently, several RCTs have shown that cervical pessary could decrease the incidence of PTB&#xD;
      in several populations.&#xD;
&#xD;
      Thus, the aim of our trial as noninferiority trial is to evaluate the efficacy of pessary&#xD;
      compared to cervical cerclage in prevention of PTB in women in the setting of mid-trimester&#xD;
      cervical dilation&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    never started&#xD;
  </why_stopped>
  <start_date type="Actual">November 2016</start_date>
  <completion_date type="Anticipated">March 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Neonatal survival</measure>
    <time_frame>From delivery to 28 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Preterm birth</measure>
    <time_frame>time of delivery</time_frame>
    <description>&lt;24, &lt;28, &lt;30 weeks. both spontaneous and indicated</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Latency</measure>
    <time_frame>time of delivery</time_frame>
    <description>Time from randomization to delivery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Birth weight</measure>
    <time_frame>time of delivery</time_frame>
    <description>in grams</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>gestational age at delivery</measure>
    <time_frame>time of delivery</time_frame>
    <description>mean of delivery</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>PreTerm Birth</condition>
  <arm_group>
    <arm_group_label>Cervical pessary</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Arabin Pessary</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cervical cerclage</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>McDonald Cerclage</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Arabin Pessary</intervention_name>
    <description>Arabin silicon pessary</description>
    <arm_group_label>Cervical pessary</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cervical cerclage</intervention_name>
    <arm_group_label>Cervical cerclage</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Singleton pregnancies&#xD;
&#xD;
          -  Cervical dilation between 1 to 5 cm and/or visible membranes by pelvic exam or&#xD;
             speculum exam between at 16-23 6/7 weeks gestation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pessary or cerclage already in situ&#xD;
&#xD;
          -  active vaginal bleeding&#xD;
&#xD;
          -  Placenta previa/accreta&#xD;
&#xD;
          -  Multiple gestations&#xD;
&#xD;
          -  Amniotic membranes prolapsed beyond external os into the vagina, unable to visualize&#xD;
             cervical tissue&#xD;
&#xD;
          -  Ruptured amniotic membranes at the time of diagnosis of dilated cervix&#xD;
&#xD;
          -  Cervical dilation more than 5 cm&#xD;
&#xD;
          -  Labor (progressing cervical dilation) or painful regular uterine contractions&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Gabriele Saccone</name>
      <address>
        <city>Napoli</city>
        <zip>80129</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>November 2018</verification_date>
  <study_first_submitted>November 11, 2016</study_first_submitted>
  <study_first_submitted_qc>November 15, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 18, 2016</study_first_posted>
  <last_update_submitted>November 15, 2018</last_update_submitted>
  <last_update_submitted_qc>November 15, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">November 19, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Federico II University</investigator_affiliation>
    <investigator_full_name>Gabriele Saccone</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Premature Birth</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

